Design
Review
Authors
Loading...
ADMA is a strong independent risk marker; leaves open whether modifying levels improves cardiovascular outcomes.
Sibal et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: